The new Behaivior start-up wants to merge artificial intelligence with wearable devices to predict relapse danger for recovering opioid users. IBM Watson AI XPRIZE participants Ryan O’Shea, Jeremy Guttman, Ellie Gordon, and James Tiu have a goal to combine treatment for opioid use with machine learning to predict behavior to create this innovative ability.
If successfully implemented, the device would gather data, such as elevated body responses or notifications of missed counseling appointments, to determine when a candidate might be in danger of a relapse. The determination would happen through a predictive model, and a message or alert would be sent to a predetermined contact for human intervention. The device could help keep wearers out of court for reasons such as relapse and related crimes, and may be an alternative to treatment centers.
Behaivior is one of 147 worldwide teams accepted into the IBM Watson AI XPRIZE, a $5 million contest focused on finding ways for humans to use artificial intelligence to solve large, real-world problems. The competition lasts four years with annual “milestone competitions” in 2017 and 2018. The top three teams as of the 2018 competition will compete for the top prize at TED 2020.
This was reported by The Incline on May 3, 2017.
Contact Information: IBM Watson AI XPRIZE, 800 Corporate Pointe, Suite 350, Culver City, CA 90230; 310-741-4880; Website: ai.xprize.org